A new study offers insight into a process that could lead one species to diverge into two, researchers report in The American Naturalist.
The historical context behind the FCC's 'net neutrality' decision
A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs with spontaneously occurring cancers, and is still in clinical trials in dogs with osteosarcoma.
More than half of patients with symptoms of mental illness – and nearly one-third of those who also had diabetes – said their health care providers had never told them to exercise or reduce their intake of dietary fat, according to a new study published in Diabetes Educator.
When exposed to nitrogen fertilizer over a period of years, nitrogen-fixing bacteria called rhizobia evolve to become less beneficial to legumes – the plants they normally serve, researchers report in a new study.